Lisbeth Elster

Horsholm, 2970, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.

Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment.

Journal: Scientific reports
Published: August 28, 2024

Machine-Learning-Guided Peptide Drug Discovery: Development of GLP-1 Receptor Agonists with Improved Drug Properties.

Machine-Learning-Guided Peptide Drug Discovery: Development of GLP-1 Receptor Agonists with Improved Drug Properties.

Journal: Journal of medicinal chemistry
Published: July 08, 2024

Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging.

Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging.

Journal: Neuropharmacology
Published: December 30, 2022

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.

Journal: Scientific reports
Published: June 01, 2021

Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization.

Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization.

Journal: Molecular pharmaceutics
Published: July 17, 2019

Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control.

Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control.

Journal: Peptides
Published: October 26, 2017

The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function.

The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function.

Journal: Bioorganic & medicinal chemistry letters
Published: September 11, 2014

Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists.

Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists.

Journal: Bioorganic & medicinal chemistry letters
Published: September 03, 2014

Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.

Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.

Journal: British journal of pharmacology
Published: March 31, 2014

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.

Journal: Bioorganic & medicinal chemistry letters
Published: January 22, 2012

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists.

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists.

Journal: Bioorganic & medicinal chemistry letters
Published: January 10, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026